［1］ DIXON SJ,LEMBERG KM,LAMPRECHT MR,et al.Ferroptosis:an iron-dependent form of nonapoptotic cell death ［J］.Cell,2012,149(5):1060-1072.
［2］ XIE Y,HOU W,SONG X,et al.Ferroptosis:process and function ［J］.Cell Death and Differentiation,2016,23(3):369-379.
［3］ ZILLE M,KARUPPAGOUNDER SS,CHEN Y,et al.Neuronal death after hemorrhagic stroke in vitro and in vivo shares features of ferroptosis and necroptosis ［J］.Stroke,2017,48(4):1033-1043.
［4］ NEITEMEIER S,JELINEK A,LAINO V,et al.BID links ferroptosis to mitochondrial cell death pathways ［J］.Redox Biology,2017,12：558-570.
［5］ STOCKWELL BR,FRIEDMANN ANGELI JP,BAYIR H,et al.Ferroptosis:A regulated cell death nexus linking metabolism,redox biology,and disease ［J］.Cell,2017,171(2):273-285.
［6］ YUAN H,LI X,ZHANG X,et al.Identification of ACSL4 as a biomarker and contributor of ferroptosis ［J］.Biochemical and Biophysical Research Communications,2016,478(3):1338-1343.
［7］ CHENG Z,LI Y.What is responsible for the initiating chemistry of iron‐mediated lipid peroxidation:An update［J］.Cheminform,2010,38(22).
［8］SEILER A,SCHNEIDER M,FORSTER H,et al.Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death ［J］.Cell Metabolism,2008,8(3):237-248.
［9］ LUO M,WU L,ZHANG K,et al.miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma ［J］.Cell Death and Differentiation,2018,25(8):1457-1472.
［10］ SHEN Z,SONG J,YUNG BC,et al.Emerging strategies of cancer therapy based on ferroptosis ［J］.Advanced Materials,2018,30(12):e1704007.
［11］ YU H,GUO P,XIE X,et al.Ferroptosis,a new form of cell death,and its relationships with tumourous diseases ［J］.Journal of Cellular and Molecular Medicine,2017,21(4):648-657.
［12］ XIE Y,ZHU S,SONG X,et al.The tumor suppressor p53 limits ferroptosis by blocking DPP4 activity ［J］.Cell Reports,2017,20(7):1692-1704.
［13］ SUN X,OU Z,CHEN R,et al.Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells ［J］.Hepatology,2016,63(1):173-184.
［14］ YAGODA N,VON RECHENBERG M,ZAGANJOR E,et al.RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels ［J］.Nature,2007,447(7146):864-868.
［15］ KANG R,KROEMER G,TANG D.The tumor suppressor protein p53 and the ferroptosis network ［J］.Free Radical Biology & Medicine,2019,133:162-168.
［16］ TARANGELO A,MAGTANONG L,BIEGING-ROLETT KT,et al.p53 suppresses metabolic stress-induced ferroptosis in cancer cells ［J］.Cell Reports,2018,22(3):569-575.
［17］ SUN X,NIU X,CHEN R,et al.Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis ［J］.Hepatology,2016,64(2):488-500.
［18］ WANG Z,DING Y,WANG X,et al.Pseudolaric acid B triggers ferroptosis in glioma cells via activation of Nox4 and inhibition of xCT ［J］.Cancer Letters,2018,428:21-33.
［19］ RECALCATI S,GAMMELLA E,CAIRO G.Dysregulation of iron metabolism in cancer stem cells ［J］.Free Radical Biology & Medicine,2019,133:216-220.
［20］ RUBIO-NAVARRO A,CARRIL M,PADRO D,et al.CD163-macrophages are involved in rhabdomyolysis-induced kidney injury and may be detected by MRI with targeted gold-coated iron oxide nanoparticles ［J］.Theranostics,2016,6(6):896-914.
［21］ ZANGANEH S,HUTTER G,SPITLER R,et al.Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues ［J］.Nature Nanotechnology,2016,11(11):986-994.
［22］ MA P,XIAO H,YU C,et al.Enhanced cisplatin chemotherapy by iron oxide nanocarrier-mediated generation of highly toxic reactive oxygen species ［J］.Nano Letters,2017,17(2):928-937.
［23］ ZHOU Z,SONG J,TIAN R,et al.Activatable singlet oxygen generation from lipid hydroperoxide nanoparticles for cancer therapy ［J］.Angewandte Chemie,2017,56(23):6492-6496.
［24］ LI WP,SU CH,CHANG YC,et al.Ultrasound-induced reactive oxygen species mediated therapy and imaging using a fenton reaction activable polymersome ［J］.ACS Nano,2016,10(2):2017-2027.
［25］ ZHANG C,BU W,NI D,et al.Synthesis of iron nanometallic glasses and their application in cancer therapy by a localized fenton reaction ［J］.Angewandte Chemie,2016,55(6):2101-2106.
［26］ ZHENG DW,LEI Q,ZHU JY,et al.Switching apoptosis to ferroptosis:Metal-organic network for high-efficiency anticancer therapy ［J］.Nano Letters,2017,17(1):284-291.
［27］ YUE L,WANG J,DAI Z,et al.pH-responsive,self-sacrificial nanotheranostic agent for potential in vivo and in vitro dual modal MRI/CT imaging,real-time,and in situ monitoring of cancer therapy ［J］.Bioconjugate Chemistry,2017,28(2):400-409.
［28］ KIM SE,ZHANG L,MA K,et al.Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth ［J］.Nature Nanotechnology,2016,11(11):977-985.
［29］ JIANG L,KON N,LI T,et al.Ferroptosis as a p53-mediated activity during tumour suppression ［J］.Nature,2015,520(7545):57-62.
［30］ DOLL S,PRONETH B,TYURINA YY,et al.ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition ［J］.Nature Chemical Biology,2017,13(1):91-98.
［31］ YUAN H,LI X,ZHANG X,et al.CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation ［J］.Biochemical and Biophysical Research Communications,2016,478(2):838-844.
［32］ SUN X,OU Z,XIE M,et al.HSPB1 as a novel regulator of ferroptotic cancer cell death ［J］.Oncogene,2015,34(45):5617-5625.
［33］ TORII S,SHINTOKU R,KUBOTA C,et al.An essential role for functional lysosomes in ferroptosis of cancer cells ［J］.The Biochemical Journal,2016,473(6):769-777.